From pipeline to patient: How Ready-to-Use vials can accelerate the drug development processWebinarReplayReady-to-Use products offered as particulate cleaned, depyrogenated and sterile primary packaging components are experiencing a rapid market adoption. Ready-to-Use vials in particular have the ability to accelerate traditional drug development journeys and support pharmaceutical and biotechnology companies in meeting the growth in demand for personalized medicines and biologics.
For more information, please contact us at webinar@avantorsciences.com Presented By: Dr. Felix Brosi is Global Head of Product Management at DWK Life Sciences. He has more than six years' experience in pharmaceutical primary packaging in customer consultancy and product management. He holds a PhD in inorganic chemistry from Freie Universität, Berlin and is passionate about cars and coffee. |
|
Bitte warten Sie...Ihre Daten werden bearbeitet |
